Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers

被引:78
|
作者
Maroun, RG
Gayet, S
Benleulmi, MS
Porumb, H
Zargarian, L
Merad, H
Leh, H
Mouscadet, JF
Troalen, FR
Fermandjian, S
机构
[1] Inst Gustave Roussy, UMR 8532 CNRS, Dept Biol & Pharmacol Struct, F-94805 Villejuif, France
[2] Inst Gustave Roussy, UMR 8532 CNRS, Lab Physiochim & Pharmacol Macromol Biol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, UMR 8532 CNRS, Lab Microchim & Immunol Mol, Dept Biol, F-94805 Villejuif, France
[4] Univ St Joseph, CST Mar Roukos, Fac Sci, Dept Sci Vie & Terre, Beirut, Lebanon
关键词
D O I
10.1021/bi011328n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integration of HIV-1 genome into host cell chromosome is mediated by viral integrase (IN). The IN catalytic core (CC, IN50-212) dimerizes through mutual interactions of its alpha1 and alpha5 helices. Peptides INH1 and INH5 reproducing these helix sequences strongly inhibited IN. For instance, an IC50 of 80 nM was determined for INH5 in integration assays using wild-type IN (wtIN). In size exclusion chromatography, INH1 and INH5 perturbed the association-dissociation equilibrium of both dmIN (IN1-288/F185K/C280S) and CC, leading to monomers as surviving species, while in circular dichroism, binding of peptides to dmIN altered the protein conformation. Thus, enzyme deactivation, subunit dissociation, and protein unfolding are events which parallel one another. The target of INH5 in the enzyme was then identified. In fluorescence spectroscopy, C-0.5 values of 168 and 44 nM were determined for the binding affinity of INH5 to IN and CC, respectively, at 115 nM subunit concentration, while interaction of INH5 with INH1 was found stronger than interaction of INH5 with itself (23 times larger in term of dissociation constants). These results strongly suggested that the alpha1 helix is the privileged target of INH5. The latter could serve as a lead for the development of new chemotherapeutic agents against HIV-1.
引用
收藏
页码:13840 / 13848
页数:9
相关论文
共 50 条
  • [1] Peptide HIV-1 Integrase Inhibitors from HIV-1 Gene Products
    Suzuki, Shintaro
    Urano, Emiko
    Hashimoto, Chic
    Tsutsumi, Hiroshi
    Nakahara, Toru
    Tanaka, Tomohiro
    Nakanishi, Yuta
    Maddali, Kasthuraiah
    Han, Yan
    Hamatake, Makiko
    Miyauchi, Kosuke
    Pommie, Yves
    Beutler, John A.
    Sugiura, Wataru
    Fuji, Hideyoshi
    Hoshino, Tyuji
    Itotani, Kyoko
    Nomura, Wataru
    Narumi, Tetsuo
    Yamamoto, Naoki
    Komano, Jun A.
    Tamamura, Hirokazu
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5356 - 5360
  • [2] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    Chmielewski, JA
    BIOPOLYMERS, 2003, 71 (03) : 397 - 397
  • [3] Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
    Zhao, L
    O'Reilly, MK
    Shultz, MD
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1175 - 1177
  • [4] The future of integrase inhibitors of HIV-1
    Malet, Isabelle
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
  • [5] The hunt for HIV-1 integrase inhibitors
    Lataillade, Max
    Kozal, Michael J.
    AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
  • [6] Arylamide inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Mazumder, A
    Sunder, S
    Pommier, Y
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194
  • [7] Thiazolothiazepine inhibitors of HIV-1 integrase
    Neamati, N
    Turpin, JA
    Winslow, HE
    Christensen, JL
    Williamson, K
    Orr, A
    Rice, WG
    Pommier, Y
    Garofalo, A
    Brizzi, A
    Campiani, G
    Fiorini, I
    Nacci, V
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341
  • [8] Authentic HIV-1 integrase inhibitors
    Liao, Chenzhong
    Marchand, Christophe
    Burke, Terrence R., Jr.
    Pommier, Yves
    Nicklaus, Marc C.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (07) : 1107 - 1122
  • [9] HIV-1 integrase crosslinked oligomers are active in vitro
    Faure, A
    Calmels, C
    Desjobert, C
    Castroviejo, M
    Caumont-Sarcos, A
    Tarrago-Litvak, L
    Litvak, S
    Parissi, V
    NUCLEIC ACIDS RESEARCH, 2005, 33 (03) : 977 - 986
  • [10] Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: Insight into the binding mode of the enzyme
    Li, Hui-Yuan
    Zawahir, Zahrah
    Song, Lai-Dong
    Long, Ya-Qiu
    Neamati, Nouri
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) : 4477 - 4486